AKTX

Akari Therapeutics
AKTX

Overview Fund Activity

10 hedge funds and large institutions have $12.9M invested in Akari Therapeutics in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$4.37M
2
SM
2
Sabby Management
Florida
$4.34M
3
BC
3
Broadfin Capital
New York
$3.06M
4
CAM
4
Cormorant Asset Management
Massachusetts
$668K
5
DCM
5
DAFNA Capital Management
California
$285K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$4.37M 673,887 +673,887 New
SM
2
Sabby Management
Florida
$4.34M 669,080 +669,080 New
BC
3
Broadfin Capital
New York
$3.06M 470,877 +470,877 New
CAM
4
Cormorant Asset Management
Massachusetts
$668K 103,000 +103,000 New
DCM
5
DAFNA Capital Management
California
$285K 43,900 +43,900 New
KCM
6
Knoll Capital Management
Florida
$151K 23,255 +23,255 New
Citigroup
7
Citigroup
New York
$16K 2,460 +2,460 New
U
8
UBS
Switzerland
$3K 395 +395 New
TRCT
9
Tower Research Capital (TRC)
New York
$3K 465 +465 New
Morgan Stanley
10
Morgan Stanley
New York
$0 7 +7 New